Potassium Replacement in Pediatrics

Introduction to Potassium Replacement

The American Academy of Pediatrics recommends initiating oral potassium supplementation at 1-3 mmol/kg/day (40-120 mg/kg/day) divided into multiple doses for infants and young children with hypokalemia, with careful monitoring of serum levels 1

The American College of Clinical Pharmacy suggests that the enteral route is as effective as the intravenous route for potassium replacement in pediatric patients and is significantly safer, eliminating the risk of arrhythmias from rapid infusion 1
Administering potassium with or after meals can help minimize gastrointestinal effects 1
Ensuring adequate fluid intake is crucial to prevent gastrointestinal irritation 1
Dividing the total dose into multiple administrations throughout the day can help avoid rapid fluctuations in blood levels 2

For patients with severe hypokalemia (K+ ≤2.5 mEq/L) with electrocardiographic changes, intravenous potassium replacement is indicated 1
The National Kidney Foundation recommends that patients with hypokalemia and active cardiac arrhythmias should receive intravenous potassium replacement 2
Patients with non-functional gastrointestinal tracts or severe neuromuscular symptoms may also require intravenous potassium replacement 2

The American Academy of Pediatrics notes that breast milk has the lowest potassium content (546 mg/L; 14 mmol/L) compared to standard commercial formulas (700-740 mg/L; 18-19 mmol/L) 1, 3
The National Kidney Foundation suggests that volumes of infant formula ≥165 mL/kg may exceed 120 mg (3 mmol) K/kg/day and may exacerbate hyperkalemia in susceptible patients 1, 3
For infants with chronic kidney disease requiring restriction, 40-120 mg (1-3 mmol/kg/day) of potassium is a reasonable starting point 3

The American College of Clinical Pharmacy recommends verifying potassium levels with a second sample to rule out spurious hypokalemia due to hemolysis during phlebotomy 1, 2
After initiating supplementation, potassium levels should be checked at 3-7 days, then every 1-2 weeks until stabilization 2
Once stable, monitoring can be done every 3 months, then every 6 months 2
Patients with renal insufficiency, heart failure, or on medications affecting potassium require more frequent monitoring 2

The National Kidney Foundation notes that hypomagnesemia is the most common cause of refractory hypokalemia and should be corrected before potassium levels can be normalized 2, 4
The goal is to achieve a magnesium level >0.6 mmol/L (>1.5 mg/dL) 2
Organic magnesium salts (aspartate, citrate, lactate) should be used instead of oxide or hydroxide due to better bioavailability 2

The American Academy of Pediatrics suggests that children on dialysis (≥5 sessions/week) rarely require potassium restriction and may develop hypokalemia 3, 4
Normokalemia can be achieved through a high-potassium diet, KCl supplements, or addition of potassium to the dialysate 3, 4

The American College of Clinical Pharmacy warns that never supplementing potassium without first checking and correcting magnesium is the most common reason for therapeutic failure 2
Avoiding potassium-containing salt substitutes in patients with hyperkalemia or a tendency towards it is recommended 1, 3, 4
Administering 60 mEq of potassium as a single dose should be avoided; instead, divide into three separate doses of 20 mEq throughout the day 2
Intravenous potassium administration that is too rapid can cause cardiac arrhythmias and cardiac arrest; rates exceeding 20 mEq/hour should only be used in extreme circumstances with continuous cardiac monitoring 2

The American College of Clinical Pharmacy recommends removing concentrated potassium chloride from clinical areas when possible, storing only in locked cabinets in critical care areas 2
Using pre-prepared IV infusions containing potassium when available can help minimize errors 2
Implementing a double-check policy for potassium administration can help ensure safety 2
Ensuring standardized and distinctive labeling and packaging can help prevent mix-ups 2

For acutely and critically ill children receiving intravenous maintenance fluids, add potassium in amounts tailored to the child’s clinical status and monitor serum potassium levels regularly to prevent hypokalemia. This recommendation is a consensus guideline (GCP‑level evidence) from the European Society of Paediatric and Neonatal Intensive Care. 5